Earnings per share for the last twelve months: Halozyme Therapeutics, Inc. (HALO)

Symbol and logo of brand Halozyme (HALO)

Adhering to environmental standards and minimizing ecological impact, Halozyme Therapeutics (HALO) is implementing digital models to automate the licensing of the ENHANZE platform. The TTM earnings per share trend clearly demonstrates the financial result, where 3.94 captures the magnitude of this parameter. The business generates revenue through royalties from pharma behemoths, converting intravenous drugs into subcutaneous injection formats to extend the lifecycle of blockbuster drugs.

HALO (Halozyme Corp) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/18/2026

Summary analytical data breakdowns for Halozyme Corp (HALO)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:HALO - Halozyme Corp
Manufactured products of Halozyme Inc.

This indicator measures the aggregate net income over four quarters divided by the total number of shares, allowing for an objective assessment of the business's actual profitability regardless of issuance factors. By analyzing the current trailing twelve-month earnings per share, an investor can see the results of Halozyme Therapeutics (HALO) monetizing its licensing rights, where a steady stream of royalties from global pharma behemoths minimizes risks and ensures sustainable growth of the metric.

Main competitors

ONC - Earnings per share for the last twelve months|RVMD - Net earnings per share (EPS TTM)|Ascentage (AAPG) - Earnings per share for the last twelve months|CG Oncology Corp - Earnings per share for the trailing year|URGN (UroGen Pharma Ltd) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bicara Therapeutics Inc. BCAX|Earnings per share for the last twelve months Personalis, Inc. (PSNL)|ERAS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) DCTH (delcath.com)|Net earnings per share for the trailing year Y-mAbs Corp|AURA - Earnings per share for the last twelve months|CADL (candeltx.com) - Earnings per share for the last 12 months|ARAY (accuray.com) - Net earnings per share for the last 12 months|SELLAS Life Sciences Group Inc. (SLS) - Net earnings per share (EPS TTM)|ACTU (Actuate Therapeutics Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Citius Oncology Inc|Net earnings per share (EPS TTM) HURA|TARA (Protara Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) FATE (Fate Therapeutics)|Net earnings per share for the last four quarters Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Net earnings per share (EPS TTM)|CSBR (Champions Oncology, Inc.) - Earnings per share for the last 12 months|XBIT (XBiotech USA) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Radiopharm Theranostics (RADX)|Net earnings per share for the last 12 months ARTV (Artiva Biotherapeutics, Inc.)|ANL - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Veru Inc. VERU|Earnings per share for the trailing year TPST|XLO: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Renovaro RENB|MURA (muraloncology.com) - Net earnings per share for the last 12 months|Kairos Pharma Inc - Earnings per share for the trailing year|Net earnings per share for the last 12 months OKUR|Net earnings per one share for the last twelve months CytoMed Therapeutics Limited GDTC|Net earnings per share (EPS TTM) CRIS|Net earnings per share (EPS TTM) Apollomics Inc. (APLM)|Net earnings per share (EPS TTM) THAR (Tharimmune Corp)|Net earnings per share for the last four quarters Advanced Biomed Inc (ADVB)|Genprex Inc - Net earnings per share (EPS TTM)|CLDI - Net earnings per share (EPS TTM)|Sunshine Biopharma Inc. (SBFM) - Earnings per share for the last twelve months|XBIO - Net earnings per share for the last four quarters|SLRX (Salarius Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Kitov Pharma|Net earnings per share for the last 12 months AONC (American Oncology Network)|BGNE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CKPT (Checkpoint Therapeutics Inc.)|Elevation Oncology, Inc. - Earnings per share for the last twelve months|ICAD - Earnings per share for the last twelve months|IKNA - Net earnings per share (EPS TTM)|Notable Labs (NTBL) - Earnings per share for the last twelve months|Earnings per share for the last 12 months VIRX|MOR (MorphoSys Corporation) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NAYA Biosciences Inc NAYA|Earnings per share for the last twelve months Ascentage Pharma (AAPGV)